EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Chinese herbal medicine for post-viral fatigue: A systematic review of randomized controlled trials

Le-Yan Hu, An-Qi Cai, Bo Li, Zheng Li, Jian-Ping Liu, Hui-Juan Cao iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0300896 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift PLOS ONE, 2024. Verfasst von Le-Yan Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Fatigue Syndrome, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the key R&D project of Xinjiang Autonomous Region: Research on key technologies of prevention and control for COVID-19, Educational science research project of Beijing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fatigue is a common symptom after viral infection. Chinese herbal medicine (CHM) is thought to be a potential effective intervention in relieving fatigue.

Purpose

To assess the effectiveness and safety of CHM for the treatment of post-viral fatigue. Study design Systematic review and meta-analysis of randomized controlled trials (RCTs).

Methods

The protocol of this systematic review was registered on PROSPERO (CRD42022380356). Trials reported changes of fatigue symptom, which compared CHM to no treatment, placebo or drugs, were included. Six electronic databases and three clinical trial registration platforms were searched from inception to November 2023. Literature screening, data extraction, and risk bias assessment were independently carried out by two reviewers. Quality of the included trials was evaluated using Cochrane risk of bias tool, and the certainty of the evidence was evaluated using GRADE. The meta-analysis was performed using Review Manager 5.4, mean difference (MD) and its 95% confidence interval (CI) was used for estimate effect of continuous data. Heterogeneity among trials was assessed through I 2 value.

Results

Overall, nineteen studies with 1921 patients were included. Results of individual trial or meta-analysis showed that CHM was better than no treatment (MD = -0.80 scores, 95%CI -1.43 to -0.17 scores, P = 0.01, 60 participants, 1 trial), placebo (MD = -1.90 scores, 95%CI -2.38 to -1.42 scores, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalFatigue Syndrome, ChronicHumansFatigueRandomized Controlled Trials as Topic

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Beijing University of Chinese Medicine, Beijing, China.
  • Traditional Chinese Medicine Hospital affiliated to Xinjiang Medical University, Ürümqi, Xinjiang, China.

ORCID-Profile: Hui-Juan Cao

Förderung

  • the key R&D project of Xinjiang Autonomous Region: Research on key technologies of prevention and control for COVID-19
  • Educational science research project of Beijing University of Chinese Medicine

Zitieren

APA

Hu, L. Y., Cai, A. Q., Li, B., Li, Z., Liu, J. P., & Cao, H. J. (2024). Chinese herbal medicine for post-viral fatigue: A systematic review of randomized controlled trials. PLOS ONE. https://doi.org/10.1371/journal.pone.0300896

Vancouver

Hu LY, Cai AQ, Li B, Li Z, Liu JP, Cao HJ. Chinese herbal medicine for post-viral fatigue: A systematic review of randomized controlled trials. PLOS ONE. 2024. doi:10.1371/journal.pone.0300896

BibTeX
@article{Hu2024,
  author = {Hu, Le-Yan and Cai, An-Qi and Li, Bo and Li, Zheng and Liu, Jian-Ping and Cao, Hui-Juan},
  title = {Chinese herbal medicine for post-viral fatigue: A systematic review of randomized controlled trials},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0300896}
}
Kostenlos starten →